Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
WuXi STA Opens Oligonucleotide Large-Scale Manufacturing Facility
Friday, January 03, 2020STA Pharmaceutical Co Ltd a subsidiary of WuXi AppTec today announced the opening of its largescale oligonucleotide active pharmaceutical ingredient API manufacturing facility in Changzhou China This significant milestone marks WuXi STAs establishm...
Pulmatrix Announces Kinase Inhibitor Licensing Agreement with Lung Cancer Initiative at Johnson & Johnson
Friday, January 03, 2020Pulmatrix Inc a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary diseases today announced that it has entered into a licensing and development agreement with the Lung Cancer Initiative at J...
Acceleron and Fulcrum Therapeutics Announce Pulmonary Research and Discovery Collaboration Agreement
Tuesday, December 31, 2019Acceleron Pharma Inc a leading biopharmaceutical company in the discovery and development of TGFbeta superfamily therapeutics to treat serious and rare diseases and Fulcrum Therapeutics Inc a clinicalstage biopharmaceutical company focused on improvi...
Savara Granted Breakthrough Therapy Designation for Molgradex
Tuesday, December 31, 2019Savara Inc an orphan lung disease company announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy designation for Molgradex an inhaled formulation of recombinant human granulocytemacrophage colonystimulating factor GMC...
Cyclo Therapeutics Signs Master Services Agreement with Worldwide Clinical Trials
Monday, December 30, 2019Cyclo Therapeutics Inc a clinicalstage biotechnology company that develops cyclodextrinbased products for the treatment of NiemannPick Disease Type C NPC and Alzheimers Disease today announced that it has signed a Master Services Agreement with World...
Astellas Strengthens Immuno-oncology Pipeline with Acquisition of Xyphos Biosciences, Inc.
Friday, December 27, 2019Astellas Pharma Inc and Xyphos Biosciences Inctoday announced that Astellas has acquired Xyphos With the acquisition Astellas will gain Xyphos novel and proprietary ACCEL Advanced Cellular Control through Engineered Ligands technology platform as wel...
GenScript and Selecxine Enter Into Strategic Cooperation Agreement
Friday, December 27, 2019South Korea the CDMO segment of the worlds leading biotech company GenScript announced that it signed a strategic collaboration agreement with Selecxine Inc a Korean biotech company dedicated to novel therapeutics for immunooncology The parties have...
Theravance Biopharma and Pfizer Inc. Enter Global License Agreement for Skin-Targeted, Locally-Acting Pan-Janus Kinase (JAK) Inhibitor Program
Tuesday, December 24, 2019Theravance Biopharma Ireland Limited a subsidiary of Theravance Biopharma Inc and Pfizer Inc today announced that the companies have entered into a global license agreement for Theravance Biopharmas preclinical program for skintargeted locallyacting...
Roche enters licensing agreement with Sarepta Therapeutics to improve the lives of patients living with Duchenne muscular dystrophy
Tuesday, December 24, 2019Roche and Sarepta Therapeutics Inc today announced the signing of a licensing agreement providing Roche exclusive commercial rights to SRP AAVrhMHCKmicrodystrophin Sareptas investigational gene therapy for Duchenne muscular dystrophy DMD outside the...
LEO Pharma Signs Agreement to Divest Emollients and Proctology Portfolio to Karo Pharma
Tuesday, December 24, 2019LEO Pharma announced the sale of products to Karo Pharma AB for MEUR The divested portfolio is noncore to LEO Pharmas business and was part of the portfolio acquired from Bayer in July
